Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

The Federal Reserve Smiles on American Express Company (AXP): Citigroup Inc. (C), SunTrust Banks, Inc. (STI)

Should You Be Worried About American Express (AXP)’s Earnings Announcement?The changes that the Federal Reserve made to its annual stress tests worked out very well for American Express Company (NYSE:AXP), which announced late yesterday that the Fed had approved its plan to return capital to investors.

The new format instituted by the Federal Reserve this year, whereby the stress test results and the Comprehensive Capital Analysis and Review scores were released separately, worked out well for American Express Company (NYSE:AXP). That’s because it was able to obtain feedback from the Fed back in January regarding its capital plan — which, as it turned out, was a non-starter. Being able to submit an amended plan enabled AmEx to get a passing grade of 6.4% for its post-super-stress scenario, compared to the 4.97% it would have gotten without the early heads-up.

Now, AmEx is able to present its shareholders with a nice dividend increase, 3% higher than last years’ hike:

As well as a not-quite-as-hefty, but still sweet, share repurchase program:

A second chance for investors, too

As the Fed found out last year, tweaks to capital plans caused quite a bit of upheaval for financial institutions, which had to wait months to see if their revised plans passed muster. Last year, SunTrust Banks, Inc. (NYSE:STI), Fifth Third Bancorp (NASDAQ:FITB), and Citigroup Inc. (NYSE:C) all had their capital plans rejected, and had to resubmit. Fifth Third was later able to boost its dividend in September, by 25%, unlike the other two banks.

SunTrust Banks, Inc. (NYSE:STI), which had been expected to pass all aspects of the testing after paying off its Troubled Asset Relief Program balance, wasn’t punished by investors, and actually saw an upward tick in its share price immediately after the results were announced in March. For Citigroup Inc. (NYSE:C), however, the news was dire, particularly for then-CEO Vikram Pandit, whose ousting last fall has been traced by many analysts to that capital plan failure in the spring.

Still a little stingy?
For investors who were hoping that American Express Company (NYSE:AXP) would be more generous with capital returns, this news might smart a little. However, I think AmEx is being cautious because of its having to submit the alternate plan when the first one didn’t fly. Better safe than sorry, as they say.

Investors needn’t worry about the company’s prospects. American Express Company (NYSE:AXP) is currently trimming its expenses, even after reporting higher-than-estimated earnings for the fourth quarter. With the economy looking brighter this year, I think it’s a sure bet that American Express Company (NYSE:AXP) won’t be letting its investors down.

The article The Federal Reserve Smiles on American Express originally appeared on Fool.com and is written by Amanda Alix.

Fool contributor Amanda Alix has no position in any stocks mentioned. The Motley Fool recommends American Express. The Motley Fool owns shares of Citigroup and Fifth Third Bancorp (NASDAQ:FITB).

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!